Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

«Bellevue Biotech – News on Alzheimers»

Last week Eisai/Biogen presented their highly anticipated data of their product candidate to treat Alzheimer’s dementia. Is this the long awaited breakthrough many have been hoping for or just data that triggers again more questions than answers?

In the Insights Video Dr. Christian Lach and Dr. Lukas Leu will provide you with the relevant background information: what is really new, how did the market react to the data, which are the most relevant competitors and what does the data mean for the healthcare sector in general.
04.10.2022 - Christian Lach, Lukas Leu
«Bellevue Biotech – News on Alzheimers»